Comparison of Biomatrix and Orsiro Drug Eluting Stent

NCT02299011 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2341

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Myocardial Ischemia

Interventions

DEVICE: Orsiro drug eluting stent
DRUG: Biomatrix drug eluting stent

Sponsor

Seoul National University Bundang Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]